Live Breaking News & Updates on Cogent Biosciences
Stay updated with breaking news from Cogent biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Forefront Analytics LLC purchased a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 19,982 shares of the technology company’s stock, valued at approximately $117,000. A number of other large investors have also made changes to their positions in COGT. AJOVista LLC acquired […] ....
Cogent Biosciences (NASDAQ:COGT) Shares Down 6.1% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cogent Biosciences Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, has appointed Cole Pinnow as chief commercial officer. ....
Wedbush reaffirmed their neutral rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $10.00 price target on the technology company’s stock. A number of other research analysts have also commented on the company. Leerink Partnrs reiterated an outperform rating on shares […] ....